Apr 2, 2019
Bio-Rad Laboratories has reported data from three clinical studies using its ddPCR-powered liquid biopsy to track cancer progression and therapy response.
Clinical diagnostic solutions maker Bio-Rad Laboratories has reported data from three clinical studies using its Droplet Digital PCR (ddPCR) powered liquid biopsy to track cancer progression and assess therapy response.